BIO pushes Congress for JOBS Act relief

GlycoMimetics Inc. (NASDAQ:GLYC) CEO Rachel King urged Congress Wednesday to relax rules for public biotech companies not yet making a profit and build on earlier legislation through the proposed JOBS and Investor Confidence Act of 2018 (JOBS Act 3.0).

King testified on behalf of BIO, where she is a former chair and a current board member...